Glucose-6-Phosphatase mRNA and Activity Are Increased to the Same Extent in Kidney and Liver of Diabetic Rats

Abstract

Using Northern blot with a specific glucose-6-phosphatase (Glc6Pase) cDNA probe and enzymatic activity determination, we studied the effect of streptozotocin-induced diabetes on Glc6Pase in rat gluconeogenic tissues. The Glc6Pase mRNA abundance was increased four to five times in both the liver and kidney of diabetic rats. This was correlated with a concomitant 130% increase in Glc6Pase catalytic subunit in both tissues. The elevated level of Glc6Pase mRNA was significantly corrected in both the liver and kidney of diabetic rats after a 12-h insulin treatment. We also studied Glc6Pase mRNA and activity in gluconeogenic tissues during the fed-fasted and fasted-refed transitions in normal rats. In the liver, the abundance of Glc6Pase mRNA was sharply increased about four times after 24 or 48 h of fasting. In the kidney, the Glc6Pase mRNA level was gradually increased some three and five times after 24 and 48 h of fasting, respectively. The increase of Glc6Pase mRNA in both organs was matched with a doubling of the activity of Glc6Pase catalytic subunit: rapid in the liver and gradual in the kidney. The liver Glc6Pase mRNA abundance in 48-h fasted rats was acutely and importantly decreased upon refeeding. The kidney Glc6Pase mRNA level was also significantly lowered under these conditions, albeit less rapidly. These data demonstrate that efficient control of Glc6Pase takes place in both gluconeogenic organs at the pretranslational level and suggest that insulin might play an important role in this control. In addition, using reverse transcription-polymerase chain reaction and Northern blot, we report that Glc6Pase mRNA is not detectable in several other tissues previously assumed to express the enzyme.

A new compartmental method for the analysis of liver FDG kinetics in small animal models

“…This reaction replenishes cytosol content of glucose to be released into the bloodstream. In agreement with this homeostatic role, liver G6Pase catalytic function is downregulated by insulin response to feeding [12] while it is markedly enhanced by the high glucagon levels occurring during fasting periods [13]. …”

“…Actually, limiting the analysis to the arterial input function (IF) inevitably causes systematic underestimation of tracer distribution in the liver [7-11]. Accordingly, several attempts have been made to estimate the dual-input IFs from dynamic PET data [8,12,13]. However, no method successfully solved this problem so far, since the PV is hard to recognize in PET images and suffers from a relevant partial-volume effect related to vessel size and respiratory movements.…”

Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin‐induced diabetic tissues by altering glycolytic and gluconeogenic enzymes

“…The increased plasma insulin and decreased glucose in diabetic rats given quercitrin may also be as a result of increased hepatic hexokinase activity, resulting in increased glycolysis. The gluconeogenic enzyme glucose-6-phosphatase is a crucial enzyme of glucose homeostasis because it catalyses the ultimate biochemical reaction of both glycogenolysis and gluconeogenesis [45]. Increased glucose 6-phosphatase activity in diabetic rats provides hydrogen, which binds with NADP+ in the form of NADPH and enhances the synthesis of fats from carbohydrates (i.e.…”

Increased renal glucose metabolism in Type 1 diabetes mellitus

“…similar blood flows). Moreover, quantitatively similar increases in renal and hepatic gluconeogenic enzymes have been found in diabetic animals [41,42], and increased gluconeogenesis appears to be the major process responsible for excessive release of glucose in human diabetes [43,44].…”